Annex 3 - WHO
Annex 3 . 121 . 1. Introduction. 1.1 Validation is an essential part of good practices, including good manufacturing practices (GMP) (6) and good clinical practices (GCP). It is therefore an element of the pharmaceutical quality system. Validation, as a concept, incorporates qualification and should be applied over the
Download Annex 3 - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Irregular Warfare Annex to the National Defense Strategy ...
media.defense.govOct 02, 2020 · This summary of the Irregular Warfare Annex to the 2018 National Defense Strategy (NDS) provides a plan to institutionalize irregular warfare (IW) as an enduring core competency for the entire Joint Force. This plan is grounded in the lessons of recent conflict.
Acceptable Means of Compliance (AMC) and Guidance …
www.easa.europa.euConsolidated unofficial AMC/GM to Annex III (Part-ORO) Page 1 European Aviation Safety Agency . Acceptable Means of Compliance (AMC) and Guidance Material (GM) to . Annex III – Part-ORO . Consolidated version including Issue 2, Amendment 61. February 2016
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu3. PHARMACEUTICAL FORM Concentrate for dispersion for injection (sterile concentrate). The vaccine is a white to off-white frozen dispersion (pH: 6.9 -7.9). 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Comirnaty 30micrograms/dose concentrate for dispersion for injection is indicated for active
EN ANNEX
www.esma.europa.eu3 ESA: ESMA, EIOPA and EBA Question ID: not available Regulation reference: Regulation (EU) 2019/2088 on sustainability‐related disclosures in the financial services Topic: sustainable finance disclosures Article: Article 4(3), Article 4(4), point (a) of Article 4(1) 1. Question As regards Article 4(4) of Regulation 2019/2088, must the calculation of the 500-employee threshold
Performance Parameters - IPCC
www.ipcc.chthat occur during its lifetime (see formula in Annex II.3.1.1) as well as on the amount of energy that is provided by the respective technol-ogy. Cash flows are usually reported in some aggregate form based on widely deployed monetary accounting principles combining cash flows into different categories of expenditures and revenues that occur at